|
1
|
Valls-Sole J and Defazio G: Blepharospasm:
Update on epidemiology, clinical aspects, and pathophysiology.
Front Neurol. 7(45)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Weiss EM, Hershey T, Karimi M, Racette B,
Tabbal SD, Mink JW, Paniello RC and Perlmutter JS: Relative risk of
spread of symptoms among the focal onset primary dystonias. Mov
Disord. 21:1175–1181. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
LeDoux MS: Meige syndrome: What's in a
name? Parkinsonism Relat Disord. 15:483–489. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pandey S and Sharma S: Meige's syndrome:
History, epidemiology, clinical features, pathogenesis and
treatment. J Neurol Sci. 372:162–170. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Defazio G, Hallett M, Jinnah HA, Conte A
and Berardelli A: Blepharospasm 40 years later. Mov Disord.
32:498–509. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dong H, Luo Y, Fan S, Yin B, Weng C and
Peng B: Screening gene mutations in Chinese patients with benign
essential blepharospasm. Front Neurol. 10(1387)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sun Y, Tsai PJ, Chu CL, Huang WC and Bee
YS: Epidemiology of benign essential blepharospasm: A nationwide
population-based retrospective study in Taiwan. PLoS One.
13(e0209558)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee JM, Baek JS, Choi HS, Kim SJ and Jang
JW: Clinical features of benign essential blepharospasm in Korean
patients. Korean J Ophthalmol. 32:339–343. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Simpson DM, Hallett M, Ashman EJ, Comella
CL, Green MW, Gronseth GS, Armstrong MJ and Gloss D: Practice
guideline update summary: Botulinum neurotoxin for the treatment of
blepharospasm, cervical dystonia, adult spasticity, and headache:
Report of the guideline development subcommittee of the American
academy of neurology. Neurology. 86:1818–1826. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Krack P and Marion MH: ‘Apraxia of lid
opening,’ a focal eyelid dystonia: Clinical study of 32 patients.
Mov Disord. 9:610–615. 1994.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ababneh OH, Cetinkaya A and Kulwin DR:
Long-term efficacy and safety of botulinum toxin A injections to
treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol.
42:254–261. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tian J, Vemula SR, Xiao J, Valente EM,
Defazio G, Petrucci S, Gigante AF, Rudzińska-Bar M, Wszolek ZK,
Kennelly KD, et al: Whole-exome sequencing for variant discovery in
blepharospasm. Mol Genet Genomic Med. 6:601–626. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hammer M, Abravanel A, Peckham E, Mahloogi
A, Majounie E, Hallett M and Singleton A: Blepharospasm: A genetic
screening study in 132 patients. Parkinsonism Relat Disord.
64:315–318. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Teng X, Qu Q, Shu Y, Gong J, Xu B and Qu
J: Genetic screening in patients of Meige syndrome and
blepharospasm. Neurol Sci. 43:3683–3694. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ozelius LJ, Hewett JW, Page CE, Bressman
SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP,
et al: The early-onset torsion dystonia gene (DYT1) encodes an
ATP-binding protein. Nat Genet. 17:40–48. 1997.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Clarimon J, Brancati F, Peckham E, Valente
EM, Dallapiccola B, Abruzzese G, Girlanda P, Defazio G, Berardelli
A, Hallett M and Singleton AB: Assessing the role of DRD5 and DYT1
in two different case-control series with primary blepharospasm.
Mov Disord. 22:162–166. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xiao J, Bastian RW, Perlmutter JS, Racette
BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek
ZK, et al: High-throughput mutational analysis of TOR1A in primary
dystonia. BMC Med Genet. 10(24)2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yoshida K: Development and validation of a
disease-specific oromandibular dystonia rating scale (OMDRS). Front
Neurol. 11(583177)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Defazio G, Matarin M, Peckham EL, Martino
D, Valente EM, Singleton A, Crawley A, Aniello MS, Brancati F,
Abbruzzese G, et al: The TOR1A polymorphism rs1182 and the risk of
spread in primary blepharospasm. Mov Disord. 24:613–616.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Misbahuddin A, Placzek MR, Chaudhuri KR,
Wood NW, Bhatia KP and Warner TT: A polymorphism in the dopamine
receptor DRD5 is associated with blepharospasm. Neurology.
58:124–126. 2002.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Augood SJ, Hollingsworth Z, Albers DS,
Yang L, Leung JC, Muller B, Klein C, Breakefield XO and Standaert
DG: Dopamine transmission in DYT1 dystonia: A biochemical and
autoradiographical study. Neurology. 59:445–448. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Asanuma K, Ma Y, Okulski J, Dhawan V,
Chaly T, Carbon M, Bressman SB and Eidelberg D: Decreased striatal
D2 receptor binding in non-manifesting carriers of the DYT1
dystonia mutation. Neurology. 64:347–349. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
van der Weijden MCM, Rodriguez-Contreras
D, Delnooz CCS, Robinson BG, Condon AF, Kielhold ML, Stormezand GN,
Ma KY, Dufke C, Williams JT, et al: A gain-of-function variant in
dopamine D2 receptor and progressive chorea and dystonia phenotype.
Mov Disord. 36:729–739. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu Y, Xing H, Yokoi F, Vaillancourt DE
and Li Y: Investigating the role of striatal dopamine receptor 2 in
motor coordination and balance: Insights into the pathogenesis of
DYT1 dystonia. Behav Brain Res. 403(113137)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Siokas V, Aloizou AM, Tsouris Z,
Michalopoulou A, Mentis AA and Dardiotis E: Risk factor genes in
patients with dystonia: A comprehensive review. Tremor Other
Hyperkinet Mov (N Y). 8(559)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Siokas V, Kardaras D, Aloizou AM,
Asproudis I, Boboridis KG, Papageorgiou E, Hadjigeorgiou GM,
Tsironi EE and Dardiotis E: BDNF rs6265 (Val66Met) polymorphism as
a risk factor for blepharospasm. Neuromolecular Med. 21:68–74.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Siokas V, Kardaras D, Aloizou AM,
Asproudis I, Boboridis KG, Papageorgiou E, Spandidos DA, Tsatsakis
A, Tsironi EE and Dardiotis E: Lack of association of the
rs11655081 ARSG gene with blepharospasm. J Mol Neurosci.
67:472–476. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Siokas V, Kardaras D, Aloizou AM, Liampas
I, Papageorgiou E, Drakoulis N, Tsatsakis A, Mitsias PD,
Hadjigeorgiou GM, Tsironi EE and Dardiotis E: CYP1A2 rs762551 and
ADORA2A rs5760423 polymorphisms in patients with blepharospasm. J
Mol Neurosci. 70:1370–1375. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Siokas V, Dardiotis E, Tsironi EE,
Tsivgoulis G, Rikos D, Sokratous M, Koutsias S, Paterakis K,
Deretzi G and Hadjigeorgiou GM: The role of TOR1A polymorphisms in
dystonia: A systematic review and meta-analysis. PLoS One.
12(e0169934)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jankovic J and Orman J: Botulinum A toxin
for cranial-cervical dystonia: A double-blind, placebo-controlled
study. Neurology. 37:616–623. 1987.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jang J and Lew H: Blink index as a
response predictor of blepharospasm to botulinum neurotoxin-A
treatment. Brain Behav. 11(e2374)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Park HS, Kim IJ, Kim EG, Ryu CS, Lee JY,
Ko EJ, Park HW, Sung JH and Kim NK: A study of associations between
CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery
disease. Sci Rep. 10(16294)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dehnavi S, Sohrabi N, Sadeghi M, Lansberg
P, Banach M, Al-Rasadi K, Johnston TP and Sahebkar A: Statins and
autoimmunity: State-of-the-art. Pharmacol Ther.
214(107614)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tall AR and Yvan-Charvet L: Cholesterol,
inflammation and innate immunity. Nat Rev Immunol. 15:104–116.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Aguilar-Ballester M, Herrero-Cervera A,
Vinué Á, Martínez-Hervás S and González-Navarro H: Impact of
cholesterol metabolism in immune cell function and atherosclerosis.
Nutrients. 12(2021)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Monje MHG and Sánchez-Ferro A: Tor1a gene
in GABApre interneurons: The new player in the ‘impaired
inhibition’ game of dystonia? Mov Disord. 33(1408)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Xiao J, Thompson MM, Vemula SR and LeDoux
MS: Blepharospasm in a multiplex African-American pedigree. J
Neurol Sci. 362:299–303. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Defazio G, Conte A, Gigante AF, Ferrazzano
G, Pellicciari R, Dagostino S, Fabbrini G and Berardelli A:
Clinical heterogeneity in patients with idiopathic blepharospasm: A
cluster analysis. Parkinsonism Relat Disord. 40:64–68.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Evinger C: Benign essential blepharospasm
is a disorder of neuroplasticity: Lessons from animal models. J
Neuroophthalmol. 35:374–379. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Karimi M, Moerlein SM, Videen TO, Luedtke
RR, Taylor M, Mach RH and Perlmutter JS: Decreased striatal
dopamine receptor binding in primary focal dystonia: A D2 or D3
defect? Mov Disord. 26:100–106. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fayers T, Shaw SR, Hau SC and Ezra DG:
Changes in corneal aesthesiometry and the sub-basal nerve plexus in
benign essential blepharospasm. Br J Ophthalmol. 99:1509–1513.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Berardelli A, Cruccu G, Kimura J,
Ongerboer de Visser BW and Valls-Solé J: The orbicularis oculi
reflexes. The international federation of clinical neurophysiology.
Electroencephalogr Clin Neurophysiol Suppl. 52:249–253.
1999.PubMed/NCBI
|
|
43
|
Frauscher B, Löscher WN, Ehrmann L,
Gschliesser V, Brandauer E, Högl B and Kofler M:
Narcolepsy-cataplexy: Deficient prepulse inhibition of blink reflex
suggests pedunculopontine involvement. J Sleep Res. 21:495–501.
2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Burgen ASV, Dickens F and Zatman LJ: The
action of botulinum toxin on the neuro-muscular junction. J
Physiol. 109:10–24. 1949.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ferrazzano G, Conte A, Fabbrini G, Bologna
M, Macerollo A, Defazio G, Hallett M and Berardelli A: Botulinum
toxin and blink rate in patients with blepharospasm and increased
blinking. J Neurol Neurosurg Psychiatry. 86:336–340.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sung Y, Nam SM and Lew H: Clinical
outcomes of individualized botulinum neurotoxin type A injection
techniques in patients with essential blepharospasm. Korean J
Ophthalmol. 29:115–120. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Xiaoxue W, Xi C and Zhibo X: Effects of
botulinum toxin type A on expression of genes in keloid
fibroblasts. Aesthet Surg J. 34:154–159. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hong B, Yao L, Ni L, Wang L and Hu X:
Antinociceptive effect of botulinum toxin A involves alterations in
AMPA receptor expression and glutamate release in spinal dorsal
horn neurons. Neuroscience. 357:197–207. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Deng Y, Huang J, Zhang H, Zhu X and Gong
Q: Association of expression of DRD2 rs1800497 polymorphism with
migraine risk in Han Chinese individuals. J Pain Res. 11:763–769.
2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zeuner KE, Acewicz A, Knutzen A, Dressler
D, Lohmann K and Witt K: Dopamine DRD2 polymorphism
(DRD2/ANNK1-Taq1A) is not a significant risk factor in writer's
cramp. J Neurogenet. 30:276–279. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tanabe LM, Kim CE, Alagem N and Dauer WT:
Primary dystonia: Molecules and mechanisms. Nat Rev Neurol.
5:598–609. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Waln O and Ledoux MS: Blepharospasm plus
cervical dystonia with predominant anterocollis: A distinctive
subphenotype of segmental craniocervical dystonia? Tremor Other
Hyperkinet Mov (N Y). 2011(tre-01-33-140-2)2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Saeirad S and LeDoux MS: TOR2A variants in
blepharospasm. Tremor Other Hyperkinet Mov (N Y).
13(44)2023.PubMed/NCBI View Article : Google Scholar
|
